HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip H Elsinga Selected Research

Sodium-Glucose Transport Proteins

11/2021GMP Compliant Synthesis of [18F]Canagliflozin, a Novel PET Tracer for the Sodium-Glucose Cotransporter 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip H Elsinga Research Topics

Disease

46Neoplasms (Cancer)
01/2024 - 02/2002
9Inflammation (Inflammations)
01/2021 - 04/2004
8Prostatic Neoplasms (Prostate Cancer)
04/2021 - 08/2011
8Glioma (Gliomas)
02/2014 - 04/2004
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2016
4Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2021 - 09/2008
3Type 2 Diabetes Mellitus (MODY)
01/2023 - 11/2021
3Melanoma (Melanoma, Malignant)
03/2022 - 12/2003
3Atherosclerotic Plaque (Atheroma)
04/2020 - 01/2013
3Cognitive Dysfunction
01/2018 - 08/2011
3Neoplasm Metastasis (Metastasis)
01/2006 - 12/2003
2Infections
05/2023 - 10/2017
2Carcinoma (Carcinomatosis)
03/2022 - 12/2005
2Brain Diseases (Brain Disorder)
12/2021 - 03/2008
2Asthma (Bronchial Asthma)
01/2021 - 01/2018
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 04/2020
2Epilepsy (Aura)
01/2018 - 01/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 07/2004
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 10/2014
2Atherosclerosis
12/2015 - 01/2013
2Memory Disorders (Memory Loss)
06/2015 - 08/2011
2Sleep Deprivation
06/2015 - 04/2015
2Neuroinflammatory Diseases
05/2014 - 03/2012
2Islet Cell Adenoma (Islet Cell Tumors)
05/2012 - 03/2008
2Laryngeal Neoplasms (Laryngeal Cancer)
12/2009 - 02/2004
2Schizophrenia (Dementia Praecox)
07/2009 - 01/2004
2Carcinoid Tumor (Carcinoid)
03/2008 - 09/2006
1Brain Neoplasms (Brain Tumor)
09/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
09/2023
1Ascites
05/2023
1Communicable Diseases (Infectious Diseases)
05/2023
1Ovarian Neoplasms (Ovarian Cancer)
12/2022
1Kidney Diseases (Kidney Disease)
12/2022
1Albuminuria
12/2022

Drug/Important Bio-Agent (IBA)

12LigandsIBA
10/2015 - 11/2004
11RadiopharmaceuticalsIBA
01/2021 - 02/2002
9sigma Receptors (sigma Receptor)IBA
10/2015 - 11/2004
8Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
05/2023 - 02/2004
7Biomarkers (Surrogate Marker)IBA
01/2024 - 01/2008
6SA 4503IBA
06/2015 - 11/2004
5BombesinIBA
01/2017 - 08/2011
5Bombesin Receptors (Bombesin Receptor)IBA
01/2017 - 08/2011
5GlucuronidaseIBA
11/2012 - 05/2010
5alovudineIBA
01/2011 - 02/2004
4Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2022 - 01/2010
4EnzymesIBA
09/2021 - 05/2010
4Proteins (Proteins, Gene)FDA Link
04/2017 - 12/2005
4fluorodopa F 18IBA
01/2015 - 09/2006
4Peptides (Polypeptides)IBA
10/2013 - 08/2011
4Adrenergic Receptors (Adrenergic Receptor)IBA
03/2008 - 01/2004
3IntegrinsIBA
11/2023 - 12/2015
3Matrix Metalloproteinases (MMPs)IBA
10/2015 - 01/2013
3Sigma-1 ReceptorIBA
06/2015 - 08/2011
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012 - 09/2006
3ProdrugsIBA
11/2012 - 05/2010
3TurpentineIBA
03/2012 - 04/2004
3Haloperidol (Haldol)FDA LinkGeneric
12/2008 - 11/2004
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 09/2013
2CanagliflozinIBA
01/2023 - 11/2021
2AntibodiesIBA
03/2022 - 05/2021
2Dopamine (Intropin)FDA LinkGeneric
09/2021 - 09/2015
2Amino AcidsFDA Link
09/2021 - 01/2008
2AzidesIBA
04/2021 - 08/2020
2Alkynes (Acetylenes)IBA
04/2021 - 08/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 04/2020
2Cholinergic Agents (Cholinergics)IBA
01/2019 - 08/2011
2Antineoplastic Agents (Antineoplastics)IBA
10/2015 - 01/2010
2Adenosine (Adenocard)FDA LinkGeneric
05/2014 - 08/2011
2Propranolol (Inderal)FDA LinkGeneric
02/2014 - 03/2008
2bombesin (7-14)IBA
10/2013 - 08/2011
2Technetium (Technetium 99m)IBA
10/2013 - 08/2011
2tricineIBA
10/2013 - 08/2011
2rimcazoleIBA
09/2013 - 12/2008
2Cytostatic AgentsIBA
11/2012 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2012 - 03/2007
2Cisplatin (Platino)FDA LinkGeneric
01/2011 - 09/2006
2CatecholaminesIBA
10/2009 - 03/2008
2Phenylalanine (L-Phenylalanine)FDA Link
09/2008 - 03/2008
2Carbidopa (Lodosyn)FDA LinkGeneric
09/2008 - 09/2006
2Somatostatin Receptors (Somatostatin Receptor)IBA
03/2008 - 09/2006
2NucleosidesIBA
01/2008 - 04/2004
2Choline (Choline Chloride)IBA
01/2008 - 02/2002
21- (4- 2'- fluoroethoxy- 3- methoxyphenethyl)- 4- (3- (4- fluorophenyl)propyl)piperazineIBA
01/2006 - 11/2004
2ThymidineIBA
04/2004 - 12/2003
1Sorbitol (Yal)FDA Link
05/2023
1SodiumIBA
01/2023
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2023
1SymportersIBA
01/2023
1Telmisartan (Micardis)FDA Link
12/2022
1EpitopesIBA
12/2022
1CreatinineIBA
12/2022
1AlbuminsIBA
12/2022
1Angiotensin Receptor AntagonistsIBA
12/2022

Therapy/Procedure

12Therapeutics
05/2021 - 12/2003
5Immunotherapy
01/2024 - 01/2018
4Drug Therapy (Chemotherapy)
11/2012 - 09/2006
3Radiotherapy
10/2013 - 12/2009
1Precision Medicine
01/2024
1Proton Therapy
09/2023
1Intravenous Injections
12/2022